ScreenerHero

BACTI-B Bactiguard Holding AB (publ)

STO · SE · Healthcare · Medical Devices · bactiguard.com
15.50SEK+0.65%Mkt Cap: 53.02M $P/E: —

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. The company also has a portfolio of wound…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc.
$32.79BUSDP/E 34.5
GEHC
GE HealthCare Technologies Inc.
$29.90BUSDP/E 15.1
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
TXG
10x Genomics, Inc.
$12.73BUSD
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
BRKR
Bruker Corporation
$9.73BUSD

Key Statistics

Company
Market Cap53.02M USD
Enterprise Value62.48M USD
Revenue (TTM)19.79M USD
Gross Profit17.66M USD
Net Income (TTM)-750.30K USD
Revenue/Share5.91 SEK
Last Price15.50 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees164
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)171.11
PEG—
EV/EBITDA20.81
EV/Revenue3.16
P/S2.66
P/B1.77
EPS (TTM)-0.24
EPS (Forward)0.09
52W Range
13.6024% of range21.60
52W High21.60 SEK
52W Low13.60 SEK
Profitability
Gross Margin85.52%
Oper. Margin-9.60%
EBITDA Margin15.17%
Profit Margin-3.63%
ROE-2.49%
ROA-1.44%
Growth
Revenue Growth11.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-142.04K USD
CapEx (TTM)547.13K USD
FCF Margin9.30%
FCF Yield3.47%
Net Debt10.86M USD
Net Debt/EBITDA3.62
Balance Sheet
Debt/Equity0.52
Current Ratio1.65
Quick Ratio1.09
Book Value/Sh8.69 SEK
Cash/Share1.24 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)21.50 SEK
Upside (mean)+38.7%
Target Range21.50 SEK – 21.50 SEK
# Analysts1
Ownership
Shares Out.31.04M
Float13.23M
Insiders37.56%
Institutions37.50%
Technical
SMA 5015.83 (-2.1%)
SMA 20016.45 (-5.8%)
Beta0.42
S&P 52W Chg14.58%
Avg Vol (30d)8.54K
Avg Vol (10d)2.28K
Technical Indicators
RSI (14)45.0
MACD-0.0647
MACD Signal-0.0119
MACD Hist.-0.0529
BB Upper16.42 SEK
BB Middle15.88 SEK
BB Lower15.33 SEK
BB Width6.84%
ATR (14)0.7267 SEK
Vol Ratio (20d)0.53x